Business Description

Baxter International Inc., founded in 1931 and headquartered in Deerfield, Illinois, United States, is a global healthcare company focused on innovative medical devices, pharmaceuticals, and biotechnology products. It is best known for its advanced renal care systems, infusion pumps, and sterile solutions, which drive recurring revenue across hospitals and home care segments. Under the leadership of CEO José E. Almeida since 2016, Baxter maintains a top-five global ranking in its core markets. The company is actively investing in next-generation therapies and digital health initiatives while expanding its footprint in emerging markets.

Everything on Baxter International Inc.

Revenue (FY2025) $11.24B
YoY growth +5.7%
Operating margin -2.7%
Direction Expanding
Gross margin 30.1%
Net margin -8.0%

Earnings Transcripts

View all transcripts ↗

Leadership & board

View leadership ↗

Share Repurchase Program

Remaining (as of March 31, 2026)
$1.30 billion
Latest FY repurchased
$0 (no shares repurchased in 2025 or 2024)

Recent SEC Filings

2026-05-08 Leadership change (directors/officers) (+2 more) View filing ↗
2026-04-30 Reported quarterly results (+1 more) View filing ↗
2026-03-19 Regulation FD disclosure View filing ↗
2026-03-16 Leadership change (directors/officers) (+1 more) View filing ↗
2026-02-12 Reported quarterly results (+2 more) View filing ↗
2025-12-22 Other event View filing ↗
2025-12-04 Entered a material agreement (+3 more) View filing ↗
2025-11-25 Entered a material agreement View filing ↗
2025-11-19 Other event View filing ↗
2025-11-19 Other event View filing ↗
2025-11-12 Leadership change (directors/officers) View filing ↗
2025-10-30 Reported quarterly results View filing ↗

More Companies

See how VectorShift works for your firm

Request Demo